Oral psoralen with UV-A (PUVA) photochemotherapy is known to cause cutaneous malignancies and has been associated with cutaneous immunosuppression. Human papillomavirus infection has also been associated with cutaneous malignancies and with immunosuppressed individuals. We therefore sought evidence of human papillomavirus infection in a patient with a long history of PUVA therapy and multiple cutaneous malignancies.
During a 15-year period, an otherwise healthy patient with psoriasis who had undergone a 10-year course of PUVA photochemotherapy developed 13 squamous cell carcinomas, eight lesions diagnosed as ''squamous cell carcinoma vs keratoacanthoma,'' 14 other keratoacanthomas, six basal cell carcinomas, one melanoma in situ, and 18 other keratinocytic dysplasias. Twenty-two of the 30 lesions tested for human papillomavirus DNA by polymerase chain reaction were positive for type 16/18, including six of the seven basal or squamous cell carcinomas tested.
We hypothesize that PUVA therapy-induced immunosuppression may play an important role in PUVA-related carcinogenesis by affecting the extent and pathogenicity of human papillomavirus infection.(Arch Dermatol. 1995;131:701-704)
Weinstock MA, Coulter S, Bates J, Bogaars HA, Larson PL, Burmer GC. Human Papillomavirus and Widespread Cutaneous Carcinoma After PUVA Photochemotherapy. Arch Dermatol. 1995;131(6):701–704. doi:10.1001/archderm.1995.01690180077014
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.